Andreas Kommer, Paul Christoph Claßen, Eva Maria Schleicher, Julia Weinmann-Menke, Karel Kostev, Christian Labenz
{"title":"慢性肾脏疾病与需要治疗的抑郁症事件相关:一项回顾性队列研究","authors":"Andreas Kommer, Paul Christoph Claßen, Eva Maria Schleicher, Julia Weinmann-Menke, Karel Kostev, Christian Labenz","doi":"10.1093/ckj/sfaf186","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Depression is one of the most common psychiatric condition in patients with chronic kidney disease (CKD). It is associated with decreased adherence and quality of life as well as increased risk for dialysis, hospitalization, and mortality. Large population-based analysis evaluating the effect of CKD on the incidence of depression are missing.</p><p><strong>Methods: </strong>We performed a retrospective cohort study investigating the incidence of depression after CKD diagnosis in a large cohort derived from the IQVIA<sup>TM</sup> Disease Analyzer database. Patients with CKD were matched to individuals without CKD using the nearest neighbor propensity score matching method. The 10-year cumulative incidence of depression was compared between the cohorts using Kaplan-Meier curves and an univariable conditional Cox regression analysis was performed to assess the association between CKD and depression, as well as antidepressant prescription.</p><p><strong>Results: </strong>Both cohorts included 165 787 individuals each, either with or without CKD. The 10-year incidence of depression was 24.2% in patients with CKD and 22.2% in patients without CKD (<i>P</i> < .001). The incidence of depression followed by an antidepressant prescription was 9.0% in the CKD cohort and 3.5% in the non-CKD cohort (<i>P</i> < .001), resulting in a hazard ratio (HR) of 2.63 (95% confidence intervals (CI) 2.51-2.75). This association was strongest in younger patients below 60 years of age (HR 6.03, 95% CI 5.17-7.01).</p><p><strong>Conclusion: </strong>In this large cohort, CKD is associated with a slightly higher incidence of depression requiring drug treatment. Clinicians caring for patients with CKD, especially younger patients, should be aware of the increased risk.</p>","PeriodicalId":10435,"journal":{"name":"Clinical Kidney Journal","volume":"18 7","pages":"sfaf186"},"PeriodicalIF":4.6000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12223368/pdf/","citationCount":"0","resultStr":"{\"title\":\"Chronic kidney disease is associated with incident depression requiring treatment: a retrospective cohort study.\",\"authors\":\"Andreas Kommer, Paul Christoph Claßen, Eva Maria Schleicher, Julia Weinmann-Menke, Karel Kostev, Christian Labenz\",\"doi\":\"10.1093/ckj/sfaf186\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Depression is one of the most common psychiatric condition in patients with chronic kidney disease (CKD). It is associated with decreased adherence and quality of life as well as increased risk for dialysis, hospitalization, and mortality. Large population-based analysis evaluating the effect of CKD on the incidence of depression are missing.</p><p><strong>Methods: </strong>We performed a retrospective cohort study investigating the incidence of depression after CKD diagnosis in a large cohort derived from the IQVIA<sup>TM</sup> Disease Analyzer database. Patients with CKD were matched to individuals without CKD using the nearest neighbor propensity score matching method. The 10-year cumulative incidence of depression was compared between the cohorts using Kaplan-Meier curves and an univariable conditional Cox regression analysis was performed to assess the association between CKD and depression, as well as antidepressant prescription.</p><p><strong>Results: </strong>Both cohorts included 165 787 individuals each, either with or without CKD. The 10-year incidence of depression was 24.2% in patients with CKD and 22.2% in patients without CKD (<i>P</i> < .001). The incidence of depression followed by an antidepressant prescription was 9.0% in the CKD cohort and 3.5% in the non-CKD cohort (<i>P</i> < .001), resulting in a hazard ratio (HR) of 2.63 (95% confidence intervals (CI) 2.51-2.75). This association was strongest in younger patients below 60 years of age (HR 6.03, 95% CI 5.17-7.01).</p><p><strong>Conclusion: </strong>In this large cohort, CKD is associated with a slightly higher incidence of depression requiring drug treatment. Clinicians caring for patients with CKD, especially younger patients, should be aware of the increased risk.</p>\",\"PeriodicalId\":10435,\"journal\":{\"name\":\"Clinical Kidney Journal\",\"volume\":\"18 7\",\"pages\":\"sfaf186\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2025-06-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12223368/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Kidney Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ckj/sfaf186\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Kidney Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ckj/sfaf186","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Chronic kidney disease is associated with incident depression requiring treatment: a retrospective cohort study.
Background: Depression is one of the most common psychiatric condition in patients with chronic kidney disease (CKD). It is associated with decreased adherence and quality of life as well as increased risk for dialysis, hospitalization, and mortality. Large population-based analysis evaluating the effect of CKD on the incidence of depression are missing.
Methods: We performed a retrospective cohort study investigating the incidence of depression after CKD diagnosis in a large cohort derived from the IQVIATM Disease Analyzer database. Patients with CKD were matched to individuals without CKD using the nearest neighbor propensity score matching method. The 10-year cumulative incidence of depression was compared between the cohorts using Kaplan-Meier curves and an univariable conditional Cox regression analysis was performed to assess the association between CKD and depression, as well as antidepressant prescription.
Results: Both cohorts included 165 787 individuals each, either with or without CKD. The 10-year incidence of depression was 24.2% in patients with CKD and 22.2% in patients without CKD (P < .001). The incidence of depression followed by an antidepressant prescription was 9.0% in the CKD cohort and 3.5% in the non-CKD cohort (P < .001), resulting in a hazard ratio (HR) of 2.63 (95% confidence intervals (CI) 2.51-2.75). This association was strongest in younger patients below 60 years of age (HR 6.03, 95% CI 5.17-7.01).
Conclusion: In this large cohort, CKD is associated with a slightly higher incidence of depression requiring drug treatment. Clinicians caring for patients with CKD, especially younger patients, should be aware of the increased risk.
期刊介绍:
About the Journal
Clinical Kidney Journal: Clinical and Translational Nephrology (ckj), an official journal of the ERA-EDTA (European Renal Association-European Dialysis and Transplant Association), is a fully open access, online only journal publishing bimonthly. The journal is an essential educational and training resource integrating clinical, translational and educational research into clinical practice. ckj aims to contribute to a translational research culture among nephrologists and kidney pathologists that helps close the gap between basic researchers and practicing clinicians and promote sorely needed innovation in the Nephrology field. All research articles in this journal have undergone peer review.